WANG LAW FIRM Let a former scientist handle your immigration affairs

 
Home    
 
 
Success Stories        
 
Contact Us      
 
 

                        Sample Cases (Aliens of extraordinary ability)

EB1A-250: The petitioner/beneficiary was a biomedical scientist and engineer (microscopy, imaging technologyand worked at a US national laboratory. He received Ph.D. in Singapore and published seventeen research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-249: The petitioner/beneficiary was a neuroscientist (monoarthritis, pain sensationand worked at a US medical school. She received Ph.D. in China and published over ten research articles. Some publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-248: The petitioner/beneficiary was a biochemist and molecular biologist (insect biology, biomedical sciencesand worked at a US medical school. He received Ph.D. in China and published about ten research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-247: The petitioner/beneficiary was a neuroscientist (pain researchand worked at a US medical school. He received Ph.D. in China and published about twenty research articles. Some publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-246: The petitioner/beneficiary was a biomedical scientist (human genetics, gene therapyand worked at a US medical school. He received Ph.D. in China and published over ten research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two months later (after RFE).

EB1A-245: The petitioner/beneficiary was an environmental scientist (agricultural chemicalsand worked at a US public university. He received Ph.D. in China and published about 40 research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-244: The petitioner/beneficiary was a biomedical scientist (cancer research, HBVand worked at a US medical school. He received Ph.D. in China and published over ten research articles. One publication was widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-243: The petitioner/beneficiary was a biomedical scientist (biomaterials, biomedical engineeringand worked at a US medical school. She received Ph.D. Japan and published about ten research articles. These publications were modestly cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-242: The petitioner/beneficiary was a biomedical scientist (drug delivery systems, pharmacologyand worked at a US Federal government agency. She received Ph.D. in the United States and published about twenty research articles. Some publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-241: The petitioner/beneficiary was a biomedical scientist (neuroscienceand worked at a US medical school. He received Ph.D. in Germany and published about ten research articles. These publications were modestly cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-240: The petitioner/beneficiary was a biomedical scientist (biomedical engineering, ultrasoundand worked at a US medical school. She received Ph.D. in the United States and published about ten research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-239: The petitioner/beneficiary was a plant and crop scientist (plant geneticsand worked at a US private research institute school. He received Ph.D. in China and published several research articles in English journals. Two publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-238: The petitioner/beneficiary was a chemical scientist (polymer scienceand worked at a US private university. He received Ph.D. in China and published over twenty research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-237: The petitioner/beneficiary was a biomedical scientist (genome architecture, gene expression regulationand worked at a US medical school. She received Ph.D. in the United States and published about ten research articles. Some publications were widely cited by others. The petition was filed in 2016 and approved two weeks later (No RFE).

EB1A-236: The petitioner/beneficiary was a biomedical scientist (Microbiology/stem cellsand worked at a US public university. He received Ph.D. in China and published over ten research articles. These publications were moderately cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-235: The petitioner/beneficiary was a biomedical scientist (developmental biology/genomicsand worked at a US medical school. He received Ph.D. in Hong Kong and published about ten research articles. These publications were moderately cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-234: The petitioner/beneficiary was an atmospheric scientist (climate changeand worked at a US public University. She received Ph.D. in the United States and published over ten research articles. One publication was widely cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-233: The petitioner/beneficiary was a financial scientist (accounting/business administrationand worked at a US community college. He received Ph.D. in China and published some research articles. He also played a critical role in an international organization. One Chinese publication was moderately cited by others. The petition was filed in 2016 and approved ten months later (after RFE, denial, and appeal to AAO).

EB1A-232: The petitioner/beneficiary was a biomedical scientist (Leukemia/protein structuresand worked at a US public university. She received Ph.D. in China and published about twenty research articles. One publication was very widely cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-231: The petitioner/beneficiary was a biomedical scientist (neurodegenerative disease/AD/PDand worked at a US medical school. He received Ph.D. in China and published about ten research articles. These publications were widely cited by others. The petition was filed in 2016 and approved two weeks later (No RFE).

EB1A-230: The petitioner/beneficiary was a materials scientist (sensors, graphene, etc.and worked at a US public university. He received Ph.D. in the United States and published about twenty research articles. Some publications were widely cited by others. The petition was filed in 2016 and approved two weeks later (No RFE).

EB1A-229: The petitioner/beneficiary was a medical scientist (cancer biomarkersand worked at a US medical school. He received Ph.D. in China and published about ten research articles. These publications were moderately cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-228: The petitioner/beneficiary was a biomedical scientist (gene transcription regulation/cancer researchand worked at a US Federal research agency. She received Ph.D. in the United States and published several research articles. Two publications were widely cited by others. The petition was filed in 2016 and approved several days later (After RFE).

EB1A-227: The petitioner/beneficiary was a biomedical scientist (neuroscience/developmental biologyand worked at a US medical school. He received Ph.D. in France and published about ten research articles. One publication was very widely cited by others. The petition was filed in 2016 and approved several months later (after RFE).

EB1A-226: The petitioner/beneficiary was a medical physicist (CT cancer diagnosisand worked at a US public university. He received Ph.D. in the United States and published about forty journal and conference research articles. These publications were modestly cited by others. The petition was filed in 2016 and approved two weeks later (No RFE).

EB1A-225: The petitioner/beneficiary was a biomedical scientist (HIV Immunologyand worked at a US Federal research institute. He received Ph.D. in the United States and published about ten research articles. One publication was widely cited by others. The petition was filed in 2016 and approved two weeks later (No RFE).

EB1A-224: The petitioner/beneficiary was a biomedical scientist (biomedical engineeringand worked at a US medical school. She received Ph.D. in the United States and published about twenty research articles. These publications were moderately cited by others. The petition was filed in 2016 and approved two weeks later (No RFE).

EB1A-223: The petitioner/beneficiary was a medical scientist (cancer/neurodegenerative diseaseand worked at a US public university. She received Ph.D. in China and published over ten research articles. Some publications were widely cited by others. The petition was filed in 2016 and approved two weeks later (No RFE).

EB1A-222: The petitioner/beneficiary was a biomedical scientist (immunologyand worked at a US medical school. He received Ph.D. in China and published about ten research articles. These publications was moderately cited by others. The petition was filed in 2016 and approved two weeks later (No RFE).

EB1A-221: The petitioner/beneficiary was a biological scientist (plant science/neuroscienceand worked at a US medical school. She received Ph.D. in the United States and published about ten research articles. Some publications were widely cited by others. The petition was filed in 2016 and approved two weeks later (No RFE).

EB1A-220: The petitioner/beneficiary was a chemist and pharmaceutical scientist (bio-detectionand worked at a US medical school. She received Ph.D. in the United States and published over ten research articles. One publication was widely cited by others. The petition was filed in 2016 and approved two weeks later (No RFE).

EB1A-219: The petitioner/beneficiary was a medical scientist (cardiovascular diseasesand worked at a US medical school. She received Ph.D. in China and published over ten research articles. These publications were moderately cited by others. The petition was filed in 2015 and approved in 2016 (After RFE).

EB1A-218: The petitioner/beneficiary was a chemist and materials scientist (energy storageand worked at a US national laboratory. She received Ph.D. in China and published over twenty research articles. These publications were widely cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-217: The petitioner/beneficiary was a medical scientist (tissue engineering and organ transplantationand worked at a US medical school. He received Ph.D. in China and published about ten research articles. These publications were moderately cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-216: The petitioner/beneficiary was a medical scientist (eye diseaseand worked at a US public university. He received Ph.D. in Germany and published about twenty research articles. One publication was widely cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-215: The petitioner/beneficiary was a medical scientist (pharmacologyand worked at a US public medical school. He received Ph.D. in China and published over ten research articles. These publications were moderately cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-214: The petitioner/beneficiary was a space scientist (solar physicsand worked at a US public university. She received Ph.D. in the United States and published about ten research articles. One publication was widely cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-213: The petitioner/beneficiary was a neuroscientist (channels, neuron identificationand worked at a US private research institute. He received Ph.D. in the United States and published over ten research articles. These publications were widely cited by others (>1200 times). The petition was filed in 2016 and approved several days later (No RFE).

EB1A-212: The petitioner/beneficiary was a biomedical scientist (breast cancerand worked at a US private medical school. She received Ph.D. in the United States and published four research articles. These publications were widely cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-211: The petitioner/beneficiary was a biomedical scientist (immunologyand worked at a US public university. He received Ph.D. in the United States and published about ten research articles. These publications were widely cited by others (>1800 times). The petition was filed in 2016 and approved several days later (No RFE).

EB1A-210: The petitioner/beneficiary was an animal scientist (poultry scienceand worked at a US public university. She received Ph.D. in the United States and published about fifteen research articles. These publications were moderately cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-209: The petitioner/beneficiary was a medical scientist (Radiology; medial imagingand worked at a US medical school. He received Ph.D. in the United States and published about ten research articles. These publications were moderately cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-208: The petitioner/beneficiary was a biomedical scientist (immunology; blood diseaseand worked at a US university. He received Ph.D. in the United States and published over ten research articles. These publications were moderately cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-207: The petitioner/beneficiary was a biomedical scientist (histone methylation; epigeneticsand worked at a US medical school. He received Ph.D. in China and published five research articles. Two publications were widely cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-206: The petitioner/beneficiary was a medical geneticist (human genetic diseasesand worked at a US medical school. He received Ph.D. in the United States and published over twenty research articles. These publications were moderately cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-205: The petitioner/beneficiary was a biomedical scientist (liver disease; pain researchand worked at a US medical school. He received Ph.D. in China and published over ten research articles. These publications were moderately cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-204: The petitioner/beneficiary was a medical scientist (cancer researchand was an M.S. graduate student at a US university. She received M.D. and Ph.D. in China and published about ten research articles. These publications were moderately cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-203: The petitioner/beneficiary was a biomedical scientist (cancer research; stem cellsand worked at a US medical school. He received Ph.D. in the United States and published over ten research articles. Some publications were widely cited by others. The petition was filed in 2016 and approved several days later (No RFE).

EB1A-202: The petitioner/beneficiary was a biomedical scientist (immunologyand worked at a US medical school. He received Ph.D. in China and published over ten research articles. Some publications were moderately cited by others. The petition was filed in 2016 and approved two weeks later (No RFE).

EB1A-201: The petitioner/beneficiary was a biomedical scientist (Endocrinology; developmental biologyand worked at a US medical school. He received Ph.D. in China and published over twenty research articles. These publications were moderately cited by others. The petition was filed in 2016 and approved two weeks later (No RFE).